If you register now, then you can choose to watch it live or later. The webinar will be available later, but without any CME points.

>LIVE:  12 September 2026, Saturday 10:00 am (UK time zone)

Agenda

• 40 minutes presentation and then 20 minutes Q&A with the host Nathan Nagel
• Incretin physiology and GLP-1 mechanism of action
• Appetite regulation and central pathway
• Overview of major GLP-1 clinical trials
• Cardiovascular outcome data and implications
• Representation of South Asian, Arab and Black populations in studies
• Evidence gaps and interpretation for real-world care
• Comparing GLP-1 agents by efficacy, dosing and safety